Literature DB >> 11168986

Role of uremic toxins in exacerbating anemia in renal failure.

I C Macdougall1.   

Abstract

The anemia associated with renal failure is largely due to inappropriate erythropoietin production. There is also good evidence, however, that substances present in uremic serum can inhibit erythropoiesis, although the exact identity of these substances and the mechanism(s) by which they exert this effect remain obscure. Candidates that have been suggested to play a role in uremic inhibition of erythropoiesis include the polyamines (such as spermine, spermidine, putrescine, and cadaverine), parathyroid hormone, and some of the inflammatory cytokines. The potential role of each of these inhibitory substances is discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168986     DOI: 10.1046/j.1523-1755.2001.59780067.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  18 in total

1.  Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Muriel P C Grooteman; Albert H A Mazairac; Marinus A van den Dorpel; Menso J Nubé; Michiel L Bots; Renée Lévesque; Piet M ter Wee; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease.

Authors:  Tomoko Kimura; Takahiro Kuragano; Kiyoko Yamamoto; Masayoshi Nanami; Yukiko Hasuike; Takeshi Nakanishi
Journal:  Int J Hematol       Date:  2018-09-19       Impact factor: 2.490

3.  Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.

Authors:  Ken Aizawa; Ryohei Kawasaki; Yoshihito Tashiro; Michinori Hirata; Koichi Endo; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2016-04-15       Impact factor: 2.490

4.  Indoxyl sulfate impairs in vitro erythropoiesis by triggering apoptosis and senescence.

Authors:  Thitinat Duangchan; Manoch Rattanasompattikul; Narong Chitchongyingcharoen; Sumana Mas-Oodi; Moltira Promkan; Nuttawut Rongkiettechakorn; Suksan Korpraphong; Aungkura Supokawej
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-25

5.  L-arginine administration reverses anemia associated with renal disease.

Authors:  Takahisa Tarumoto; Shigehiko Imagawa; Makoto Kobayashi; Aki Hirayama; Keiya Ozawa; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 6.  Anaemia in kidney disease: harnessing hypoxia responses for therapy.

Authors:  Mark J Koury; Volker H Haase
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

7.  Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently.

Authors:  Carolien M S Schophuizen; Joost G J Hoenderop; Rosalinde Masereeuw; Lambert P van den Heuvel
Journal:  Cells       Date:  2015-06-26       Impact factor: 6.600

8.  Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis.

Authors:  Keiji Hirai; Hiroaki Nonaka; Moeka Ueda; Junki Morino; Shohei Kaneko; Saori Minato; Yuko Mutsuyoshi; Katsunori Yanai; Hiroki Ishii; Momoko Matsuyama; Taisuke Kitano; Akinori Aomatsu; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Front Med (Lausanne)       Date:  2021-07-07

9.  Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST).

Authors:  Neelke C van der Weerd; Claire H Den Hoedt; Peter J Blankestijn; Michiel L Bots; Marinus A van den Dorpel; Renée Lévesque; Albert H A Mazairac; Menso J Nubé; E Lars Penne; Pieter M ter Wee; Muriel P C Grooteman
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

10.  Iron Status of Cats with Chronic Kidney Disease.

Authors:  J Gest; C Langston; A Eatroff
Journal:  J Vet Intern Med       Date:  2015-09-29       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.